» Authors » Meritxell Gironella

Meritxell Gironella

Explore the profile of Meritxell Gironella including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 56
Citations 1947
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Marcuello M, Duran-Sanchon S, Moreno L, Lozano J, Bujanda L, Castells A, et al.
Cancers (Basel) . 2019 Oct; 11(10). PMID: 31614785
Early detection of colorectal cancer (CRC) and its precancerous lesion, advanced adenomas (AA), is critical to improve CRC incidence and prognosis. Circulating microRNAs (miRNAs or miR) are promising non-invasive biomarkers...
12.
Marcuello M, Vymetalkova V, Neves R, Duran-Sanchon S, Vedeld H, Tham E, et al.
Mol Aspects Med . 2019 Jun; 69:107-122. PMID: 31189073
New non-invasive approaches that can complement and improve on current strategies for colorectal cancer (CRC) screening and management are urgently needed. A growing number of publications have documented that components...
13.
Vila-Navarro E, Duran-Sanchon S, Vila-Casadesus M, Moreira L, Gines A, Cuatrecasas M, et al.
Clin Transl Gastroenterol . 2019 Apr; 10(4):e00029. PMID: 31009404
Objectives: Pancreatic ductal adenocarcinoma (PDAC) presents the lowest survival rate of all cancers because only 6% of patients reach five-year survival. Alterations in the expression of several microRNAs (miRNAs) occur...
14.
Herreros-Villanueva M, Duran-Sanchon S, Martin A, Perez-Palacios R, Vila-Navarro E, Marcuello M, et al.
Clin Transl Gastroenterol . 2019 Mar; 10(3):e00031. PMID: 30913126
No abstract available.
15.
Herreros-Villanueva M, Duran-Sanchon S, Martin A, Perez-Palacios R, Vila-Navarro E, Marcuello M, et al.
Clin Transl Gastroenterol . 2019 Feb; 10(1):e00003. PMID: 30702491
Objectives: Specific microRNA (miRNA) signatures in biological fluids can facilitate earlier detection of the tumors being then minimally invasive diagnostic biomarkers. Circulating miRNAs have also emerged as promising diagnostic biomarkers...
16.
Luna J, Boni J, Cuatrecasas M, Bofill-De Ros X, Nunez-Manchon E, Gironella M, et al.
Gut . 2018 Oct; 68(8):1465-1476. PMID: 30343272
Background And Aims: Pancreatic ductal adenocarcinoma (PDAC) is a very aggressive tumour with a poor prognosis using current treatments. Targeted therapies may offer a new avenue for more effective strategies....
17.
Rovira-Rigau M, Raimondi G, Marin M, Gironella M, Alemany R, Fillat C
Mol Ther . 2018 Oct; 27(1):230-243. PMID: 30341009
Oncolytic viruses are designed for cancer treatment. Cell-virus interactions are key determinants for successful viral replication. Therefore, the extensive reprogramming of gene expression that occurs in tumor cells might create...
18.
Paquet-Fifield S, Koh S, Cheng L, Beyit L, Shembrey C, Molck C, et al.
Cancer Res . 2018 Mar; 78(11):2925-2938. PMID: 29510994
Posttreatment recurrence of colorectal cancer, the third most lethal cancer worldwide, is often driven by a subpopulation of cancer stem cells (CSC). The tight junction (TJ) protein claudin-2 is overexpressed...
19.
Vila-Casadesus M, Vila-Navarro E, Raimondi G, Fillat C, Castells A, Lozano J, et al.
Oncotarget . 2018 Feb; 9(5):6499-6517. PMID: 29464088
MiRNAs are small non-coding RNAs that post-transcriptionally regulate gene expression. They play important roles in cancer but little is known about the specific functions that each miRNA exerts in each...
20.
Franch-Exposito S, Esteban-Jurado C, Garre P, Quintanilla I, Duran-Sanchon S, Diaz-Gay M, et al.
J Genet Genomics . 2018 Feb; 45(1):41-45. PMID: 29396139
No abstract available.